Drugs that contain Levonorgestrel

1. List of Kyleena drug patents

KYLEENA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7252839 BAYER HLTHCARE Delivery system and a manufacturing process of a delivery system
Nov, 2023

(7 months from now)

US9615965 BAYER HLTHCARE Inserter
Sep, 2029

(6 years from now)

US10561524 BAYER HLTHCARE Inserter
Sep, 2029

(6 years from now)

US10987244 BAYER HLTHCARE Inserter
Apr, 2031

(8 years from now)

US9668912 BAYER HLTHCARE Inserter
Apr, 2031

(8 years from now)

Market Authorisation Date: 16 September, 2016

Treatment: A method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system; A method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus

Dosage: INTRAUTERINE DEVICE;INTRAUTERINE

More Information on Dosage

KYLEENA family patents

19

United States

6

Finland

4

European Union

3

Portugal

3

Russia

3

Spain

3

Brazil

3

Croatia

3

Mexico

3

China

3

Korea, Republic of

3

Hong Kong

3

South Africa

3

Canada

3

Japan

3

Israel

3

Poland

3

Australia

3

Denmark

1

Germany

1

Costa Rica

1

New Zealand

1

Norway

1

Argentina

1

Austria

1

Taiwan, Province of China

1

Slovenia

1

Ukraine

1

Ecuador

2. List of Liletta drug patents

LILETTA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11090186 MEDICINES360 Methods for using intrauterine systems and IUD insertion devices
Oct, 2033

(10 years from now)

US10028858 MEDICINES360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
Mar, 2034

(11 years from now)

US11571328 MEDICINES360 NA
Sep, 2040

(17 years from now)

Market Authorisation Date: 26 February, 2015

Treatment: A method for prevention of pregnancy

Dosage: INTRAUTERINE DEVICE;INTRAUTERINE

More Information on Dosage

LILETTA family patents

5

United States

2

Brazil

2

South Africa

2

Canada

2

Australia

1

Spain

1

Colombia

1

New Zealand

1

Mexico

1

Peru

1

China

1

Korea, Republic of

1

Hong Kong

1

EA

1

Japan

1

Ukraine

1

Georgia

1

Chile

1

European Union

3. List of Mirena drug patents

MIRENA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9615965 BAYER HLTHCARE Inserter
Sep, 2029

(6 years from now)

US10561524 BAYER HLTHCARE Inserter
Sep, 2029

(6 years from now)

US10987244 BAYER HLTHCARE Inserter
Apr, 2031

(8 years from now)

US9668912 BAYER HLTHCARE Inserter
Apr, 2031

(8 years from now)

Exclusivity Exclusivity Expiration
New Dosing Schedule (D) Aug 20, 2023

Market Authorisation Date: 06 December, 2000

Treatment: A method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system; A method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus

Dosage: INTRAUTERINE DEVICE;INTRAUTERINE

More Information on Dosage

MIRENA family patents

18

United States

5

Finland

2

Portugal

2

Russia

2

Spain

2

Brazil

2

Croatia

2

Mexico

2

China

2

Korea, Republic of

2

Hong Kong

2

South Africa

2

Canada

2

Japan

2

Israel

2

Poland

2

Australia

2

Denmark

2

European Union

1

Argentina

1

Taiwan, Province of China

4. List of Skyla drug patents

SKYLA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7252839 BAYER HLTHCARE Delivery system and a manufacturing process of a delivery system
Nov, 2023

(7 months from now)

US9615965 BAYER HLTHCARE Inserter
Sep, 2029

(6 years from now)

US10561524 BAYER HLTHCARE Inserter
Sep, 2029

(6 years from now)

US10987244 BAYER HLTHCARE Inserter
Apr, 2031

(8 years from now)

US9668912 BAYER HLTHCARE Inserter
Apr, 2031

(8 years from now)

Market Authorisation Date: 09 January, 2013

Treatment: A method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system; A method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus

Dosage: INTRAUTERINE DEVICE;INTRAUTERINE

More Information on Dosage

SKYLA family patents

19

United States

6

Finland

4

European Union

3

Portugal

3

Russia

3

Spain

3

Brazil

3

Croatia

3

Mexico

3

China

3

Korea, Republic of

3

Hong Kong

3

South Africa

3

Canada

3

Japan

3

Israel

3

Poland

3

Australia

3

Denmark

1

Germany

1

Costa Rica

1

New Zealand

1

Norway

1

Argentina

1

Austria

1

Taiwan, Province of China

1

Slovenia

1

Ukraine

1

Ecuador

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic